The Côte d’ivoire Ethics Capacity Building Initiative (CECaBI) is a consortium of different partners whose objectives are to strengthen the knowledge and skills of the senior members of the National Ethics Committee for Life Sciences and Ivorian Authorities of Pharmaceutical Regulation (Autorités Ivoiriennes de Régulation Pharmaceutique (AIRP)), on how to conduct high-quality ethics reviews, ensure optimal protection of research participants, and effectively manage and coordinate clinical trials.
Pharmalys is part of this initiative. As such, Karim Bagaté, Director of Clinical Operations & Safety delivered a capacity building programme in Côte d’Ivoire in 2023. The training was delivered in two parts. The first one, in March 2023, was about the Good Clinical Practice (GCP) guidelines and site inspection. The second part, in October 2023 was a refresher on GCP with very practical exercises and workshops and a site inspection visit.
The underrepresentation of racial and ethnic minority groups in randomised controlled clinical trials limits the generalisability of healthcare findings
In recent years, growing concern has been raised regarding the lack of diversity in health and clinical research trials. As an increasing number of studies investigate the underrepresentation of racial and ethnic minority groups in health research, a notable discourse...